Fragment-based ligand discovery meets phage display

Daniel A Erlanson1

  • 1Sunesis Pharmaceuticals, Inc., 341 Oyster Point Boulevard, South San Francisco, California 94080, USA. erlanson@sunesis.com

ACS Chemical Biology
|December 25, 2007
PubMed

Related Concept Videos